MA 02.06 BRAF Mutant NSCLC: Correlation with PD-L1 Expression,TMB, MSI and Response to ICPi and Anti-BRAF Therapy
Autor: | Dudnik, E., Peled, N., Wollner, M., Onn, A., Agbareya, A., Nechushtan, H., Kuznetsov, T., Roisman, L., Rozenblum, A. Belilovski, Geva, S., Zer, A., Bar, J. |
---|---|
Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1804-S1805 |
Databáze: | ScienceDirect |
Externí odkaz: |